Additionally, the ligands of these immune checkpoint molecules, such as Galectin-3 and PD-L1, can induce T-cell apoptosis and support the differentiation of TREG, further suppressing effective anti-tumor immunity [116,117]. This evidence concerns the gene CD274 and neoplasm.